Healthcare
VC-backed TxCell launches IPO
Company plans to list in mid-April
Ratos’s Biolin Scientific sells Osstell
Listed private equity house Ratos streamlines Biolin
VC-backed Supersonic aims for €60m IPO
Company is backed by VCs including EdRip and Omnes
Q&A: Tommy Seddon, Riverside
How to find quality deals in the increasingly competitive UK mid-market
VC-backed Mainstay announces intention to float
Medical therapy developer to sell shares on Euronext Paris and Irish Stock Exchange
Industrifonden and Pegroco exit Scandinavian Air Ambulance
SAA buyer subsequently bought by Babcock for €2bn
CVC acquires Synsam
Sale process launched in 2012
Nextech hires ex-Centrum Bank CEO as new partner
Lips also held roles at Falcon Private Bank and Goldman Sachs
Xeraya Capital leads €20m Invendo funding
TVM, Wellington and 360° also partake in round
VC-backed Horizon Discovery raises £68.6m for IPO
Offering gives company £120.5m market cap
ZernikeMeta et al. invest €2m in CellPly
The company is developing in-vitro cancer treatments
GI-backed Cambian announces IPO
Business expected to raise £20m in flotation
Ysios Capital launches second fund
VC targeting €100m for life sciences fund
VC firms exit Activaero in trade sale
€130m proceeds to be split between cash and shares
EdRip, Sofinnova lead €18m round for Inotrem
Biomed Invest and Inserm Transfert Initiative also take part
VC-backed Circassia valued at £581m for IPO
Largest LSE IPO of VC- or PE-backed UK healthcare company in decade
Deal in focus: Montagu enters Dutch market with Dorc purchase
Ophthalmic surgery instruments producer generates €80m turnover
LSP closes Health Economics Fund on €112m
Vehicle began investing in September 2012
Magnum Capital buys Geriátricos del Principado
Deal leverages the GP's experience in the retirement home sector
Montagu acquires Arkopharma
Pythotherapy business generates €200m turnover
High-Tech Gründerfonds invests in Desino
Business angel joins to complete first financing round
Demeter and Emertec inject €1.8m into Ynsect
French biotech operates large-scale insect farm
Deal in focus: GC Aesthetics receives $60m lift
Management targeting 30% growth per annum
VC-backed Horizon Discovery plans £25m IPO
Horizon Discovery Group, a Cambridge-based biotech backed by DFJ Esprit and Roche Venture Fund among others, is planning to raise £25m in its IPO on the AIM segment of the London Stock Exchange.